4//SEC Filing
Murray Mark Anthony 4
Accession 0000899243-19-026594
CIK 0001720725other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:50 PM ET
Size
7.2 KB
Accession
0000899243-19-026594
Insider Transaction Report
Form 4
Murray Mark Anthony
Director
Transactions
- Conversion
Series A Convertible Preferred Stock
2019-11-04−106,517→ 0 total→ Common Stock, par value $0.001 per share (106,517 underlying) - Conversion
Common Stock, par value $0.001 per share
2019-11-04+106,517→ 108,447 total
Footnotes (1)
- [F1]These shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, $0.001 par value per share ("Common Stock"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series A Convertible Preferred Stock had no expiration date.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791443
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 5:50 PM ET
- Size
- 7.2 KB